Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.7B | -17.5B | 26.4B | 79.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 13.7B | 13.8B | 13.3B | 13.8B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | -3.0B | -31.4B | 13.1B | 65.6B |
| Tax provision | 59M | 344M | 347M | 483M |
| Net income | -3.0B | -31.7B | 12.8B | 65.1B |
| Basic EPS | -1.0 | -10.4 | 4.2 | 21.3 |
| Diluted EPS | -1.0 | -10.4 | 4.2 | 21.3 |
| Basic average shares | 3.1B | 3.1B | 3.1B | 3.1B |
| Diluted average shares | 3.1B | 3.1B | 3.1B | 3.1B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 16M | 17M | 17M | 57M |
| Preferred stock dividends | — | — | — | — |